{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:48:13Z","timestamp":1790992093018,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2016208"],"award-info":[{"award-number":["TYH2016208"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background and aims<\/jats:title>\n<jats:p>Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease that leads to bile duct strictures, cholestasis, and biliary cirrhosis. PNPLA3 (patatin-like phospholipase domain containing 3), regulates cellular lipid synthesis by converting lysophosphatidic acid into phosphatidic acid. Isoleucine mutation to methionine at position 148 (I148M) causes a loss of this function. Only two studies, with contradictory results, have evaluated the role of PNPLA3 in PSC. The rs738409(G) variant of PNPLA3 has been associated with an increased risk for transplantation in male patients with dominant strictures (DS). The study aimed to evaluate the PNPLA3 allele frequency effect on the clinical outcomes, progression, and prognosis of PSC. Furthermore, we analyzed the impact of PNPLA3 on phospholipid and bile acid composition to evaluate the effect of the PNPLA3 status on UDCA response.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Patients and methods<\/jats:title>\n<jats:p>We recruited 560 patients prospectively and collected clinical and laboratory data as well as liver histology and imaging findings. PNPLA3 (CC, CG, GG) alleles were analyzed with TaqManTM. We also analyzed bile acids (BA), cholesterol and phospholipids and individual BA from a sample aspirated during endoscopic retrograde cholangiography (ERC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among the recruited patients, 58.4%, 35.7% and 5.9% had the wild (CC), heterozygous (CG) and homozygous (GG) alleles, respectively. The PNPLA3 haplotype did not impact bile composition or individual BA. In addition, we found no differences in age at diagnosis, disease progression, liver fibrosis or survival between the cohorts.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The PNPLA3 I148M variant had no significant impact on on bile composition, including UDCA content, clinical outcomes, progression of liver fibrosis, hepatobiliary cancer risk, liver transplantation, or overall survival.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0277084","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:56:27Z","timestamp":1669924587000},"page":"e0277084","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis"],"prefix":"10.1371","volume":"17","author":[{"given":"Martti","family":"F\u00e4rkkil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Arola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"pone.0277084.ref001","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"JK Dyson","year":"2018","journal-title":"Lancet"},{"key":"pone.0277084.ref002","first-page":"293","article-title":"Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment","volume":"14","author":"JH Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"pone.0277084.ref003","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"A Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0277084.ref004","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"S-G Ji","year":"2017","journal-title":"Nat Genet"},{"key":"pone.0277084.ref005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"GF Mells","year":"2013","journal-title":"J Autoimmun"},{"key":"pone.0277084.ref006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 gene in liver diseases","volume":"65","author":"E Tr\u00e9po","year":"2016","journal-title":"J Hepatol"},{"key":"pone.0277084.ref007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"M Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"pone.0277084.ref008","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"C Pirazzi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"pone.0277084.ref009","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"JC Chambers","year":"2011","journal-title":"Nat Genet"},{"key":"pone.0277084.ref010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MIB.0000000000000569","article-title":"PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes","volume":"22","author":"RM Mancina","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0277084.ref011","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation","volume":"71","author":"F Chen","year":"2020","journal-title":"Hepatology"},{"key":"pone.0277084.ref012","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"U Beuers","year":"2010","journal-title":"Hepatology"},{"key":"pone.0277084.ref013","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2013.03.015","article-title":"Update on primary sclerosing cholangitis","volume":"59","author":"TH Karlsen","year":"2013","journal-title":"J Hepatol"},{"key":"pone.0277084.ref014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3-umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"S Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"pone.0277084.ref015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"TH Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"pone.0277084.ref016","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"T Folseraas","year":"2012","journal-title":"J Hepatol"},{"key":"pone.0277084.ref017","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"P Fickert","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0277084.ref018","doi-asserted-by":"crossref","first-page":"e58734","DOI":"10.1371\/journal.pone.0058734","article-title":"A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis","volume":"8","author":"K Friedrich","year":"2013","journal-title":"PLoS One"},{"key":"pone.0277084.ref019","doi-asserted-by":"crossref","first-page":"e0202942","DOI":"10.1371\/journal.pone.0202942","article-title":"PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC","volume":"13","author":"B Kruk","year":"2018","journal-title":"PLoS One"},{"key":"pone.0277084.ref020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"PP Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"key":"pone.0277084.ref021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis","volume":"58","author":"S1 Al Mamari","year":"2013","journal-title":"J Hepatol"},{"key":"pone.0277084.ref022","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12979","article-title":"Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis","volume":"40","author":"C Rupp","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0277084.ref023","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"R Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"pone.0277084.ref024","unstructured":"EASL Clinical Practice Guidelines on Sclerosing Cholangitis. European Association for the Study of the Liver. J Hepatol. 2022: S0168-8278(22)00326-9."},{"key":"pone.0277084.ref025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mrfmmm.2005.01.008","article-title":"Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System","volume":"573","author":"FM De la Vega","year":"2005","journal-title":"Mutat Res"},{"key":"pone.0277084.ref026","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0041-110792","article-title":"Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia","volume":"48","author":"S Boyd","year":"2016","journal-title":"Endoscopy"},{"key":"pone.0277084.ref027","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"N Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"pone.0277084.ref028","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-2275(20)39310-X","article-title":"Quantitative isolation and gas-liquid chromatographic analysis of fecal bile acids","volume":"6","author":"SM Grundy","year":"1965","journal-title":"J Lipid Res"},{"key":"pone.0277084.ref029","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jep.12254","article-title":"Combining propensity score-based stratification and weighting to improve causal inference in the evaluation of health care interventions","volume":"20","author":"A. Linden","year":"2014","journal-title":"J Eval ClinPract"},{"key":"pone.0277084.ref030","first-page":"255","volume-title":"The analysis of covariance and alternatives","author":"BE Uitema","year":"1980"},{"key":"pone.0277084.ref031","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"pone.0277084.ref032","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"S. Sookoian","year":"2009","journal-title":"J. Lipid Res"},{"key":"pone.0277084.ref033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2017.01.018","article-title":"Morgan MY. Thursz MR. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis","volume":"67","author":"SR Atkinson","year":"2017","journal-title":"J Hepatol"},{"key":"pone.0277084.ref034","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/hep.29041","article-title":"The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells","volume":"65","author":"FV Bruschi","year":"2017","journal-title":"Hepatology"},{"key":"pone.0277084.ref035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/apt.15722","article-title":"The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis","volume":"51","author":"Y-S Mederacke","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0277084.ref036","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.26767","article-title":"Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data","volume":"59","author":"E Tr\u00e9po","year":"2014","journal-title":"Hepatology"},{"key":"pone.0277084.ref037","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"L PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"P Dongiovanni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"pone.0277084.ref038","article-title":"Bile Acid Profiles in Primary Sclerosing Cholangitis and their Ability to Predict Hepatic Decompensation","author":"OY Mousa","year":"2020","journal-title":"Hepatology"},{"key":"pone.0277084.ref039","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"J Sabino","year":"2016","journal-title":"Gut"},{"key":"pone.0277084.ref040","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth","volume":"105","author":"A Monga Kravetz","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0277084.ref041","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"A Kotronen","year":"2009","journal-title":"Diabetologia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:56:54Z","timestamp":1669924614000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277084"}},"subtitle":[],"editor":[{"given":"Antonio","family":"De Vincentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277084","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}